TY - JOUR
T1 - Ethanolamine: A Potential Promoiety with Additional Effects on the Brain
T2 - A Potential Promoiety with Additional Effects on the Brain
AU - Gwanyanya, Asfree
AU - Godsmark, Christie Nicole
AU - Kelly-Laubscher, Roisin
N1 - Publisher Copyright:
© 2022 Bentham Science Publishers.
PY - 2022/2
Y1 - 2022/2
N2 - Ethanolamine is a bioactive molecule found in several cells, including those in the central nervous system (CNS). In the brain, ethanolamine and ethanolamine-related molecules have emerged as prodrug moieties that can promote drug movement across the blood-brain barrier. This improvement in the ability to target drugs to the brain may also mean that in the process, ethano-lamine concentrations in the brain are increased enough for ethanolamine to exert its own neurological actions. Ethanolamine and its associated products have various positive functions ranging from cell signaling to molecular storage, and alterations in their levels have been linked to neurodegener-ative conditions such as Alzheimer’s disease. This mini-review focuses on the effects of ethano-lamine on the CNS and highlights the possible implications of these effects for drug design.
AB - Ethanolamine is a bioactive molecule found in several cells, including those in the central nervous system (CNS). In the brain, ethanolamine and ethanolamine-related molecules have emerged as prodrug moieties that can promote drug movement across the blood-brain barrier. This improvement in the ability to target drugs to the brain may also mean that in the process, ethano-lamine concentrations in the brain are increased enough for ethanolamine to exert its own neurological actions. Ethanolamine and its associated products have various positive functions ranging from cell signaling to molecular storage, and alterations in their levels have been linked to neurodegener-ative conditions such as Alzheimer’s disease. This mini-review focuses on the effects of ethano-lamine on the CNS and highlights the possible implications of these effects for drug design.
KW - Brain
KW - CNS
KW - Ethanolamine
KW - Neuromodulator
KW - Phospholipids
KW - Prodrug
KW - Synaptic
UR - https://doi.org/10.2174/1871527319999201211204645
UR - https://www.scopus.com/pages/publications/85123646015
U2 - 10.2174/1871527319999201211204645
DO - 10.2174/1871527319999201211204645
M3 - Article
C2 - 33319663
VL - 21
SP - 108
EP - 117
JO - CNS & Neurological Disorders - Drug Targets
JF - CNS & Neurological Disorders - Drug Targets
IS - 2
ER -